The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib
BackgroundDifferent peripheral blood markers have been reported to be involved in different stages of breast cancer development and metastasis. However, the association between NLR, LDH and prognosis of pyrotinib in HER2-positive metastatic breast cancer (mBC) remains unknown.MethodsWe collected the...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2026-05-01
|
| Reeks: | Frontiers in Oncology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1812069/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|